PT1347055E - Compostos para imunoterapia e diagnóstico da tuberculose - Google Patents

Compostos para imunoterapia e diagnóstico da tuberculose Download PDF

Info

Publication number
PT1347055E
PT1347055E PT03005931T PT03005931T PT1347055E PT 1347055 E PT1347055 E PT 1347055E PT 03005931 T PT03005931 T PT 03005931T PT 03005931 T PT03005931 T PT 03005931T PT 1347055 E PT1347055 E PT 1347055E
Authority
PT
Portugal
Prior art keywords
tuberculosis
compounds
diagnosis
immunotherapy
polypeptides
Prior art date
Application number
PT03005931T
Other languages
English (en)
Inventor
Steven G Reed
Antonio Campos-Neto
Raymond L Houghton
Daniel R Twardzik
Thomas S Vedvick
Davin C Dillon
Yasir A W Skeiky
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27541835&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1347055(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of PT1347055E publication Critical patent/PT1347055E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT03005931T 1995-09-01 1996-08-30 Compostos para imunoterapia e diagnóstico da tuberculose PT1347055E (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US52343695A 1995-09-01 1995-09-01
US53363495A 1995-09-22 1995-09-22
US62087496A 1996-03-22 1996-03-22
US65968396A 1996-06-05 1996-06-05
US68057496A 1996-07-12 1996-07-12

Publications (1)

Publication Number Publication Date
PT1347055E true PT1347055E (pt) 2009-06-19

Family

ID=27541835

Family Applications (4)

Application Number Title Priority Date Filing Date
PT01126628T PT1203817E (pt) 1995-09-01 1996-08-30 Compostos e metodos para imunoterapia e le diagnostic de tuberculose
PT96933009T PT851927E (pt) 1995-09-01 1996-08-30 Compostos para imunoterapia e diagnostico de tuberculose
PT03021501T PT1398379E (pt) 1995-09-01 1996-08-30 Compostos para imunoterapia e diagnóstico de tuberculose
PT03005931T PT1347055E (pt) 1995-09-01 1996-08-30 Compostos para imunoterapia e diagnóstico da tuberculose

Family Applications Before (3)

Application Number Title Priority Date Filing Date
PT01126628T PT1203817E (pt) 1995-09-01 1996-08-30 Compostos e metodos para imunoterapia e le diagnostic de tuberculose
PT96933009T PT851927E (pt) 1995-09-01 1996-08-30 Compostos para imunoterapia e diagnostico de tuberculose
PT03021501T PT1398379E (pt) 1995-09-01 1996-08-30 Compostos para imunoterapia e diagnóstico de tuberculose

Country Status (24)

Country Link
EP (5) EP0851927B1 (pt)
JP (5) JP4382160B2 (pt)
KR (1) KR100433750B1 (pt)
CN (1) CN1117149C (pt)
AT (5) ATE426025T1 (pt)
AU (1) AU727602B2 (pt)
BR (2) BR9610262B1 (pt)
CA (3) CA2653566C (pt)
CY (2) CY2570B1 (pt)
CZ (3) CZ297406B6 (pt)
DE (4) DE69630457T2 (pt)
DK (4) DK1203817T3 (pt)
ES (4) ES2210392T3 (pt)
HK (1) HK1059282A1 (pt)
HU (2) HU225979B1 (pt)
IL (1) IL123506A (pt)
MX (1) MX9801638A (pt)
NO (4) NO324372B1 (pt)
NZ (1) NZ319377A (pt)
PL (1) PL186774B1 (pt)
PT (4) PT1203817E (pt)
SI (1) SI0851927T1 (pt)
TR (5) TR200806259T2 (pt)
WO (1) WO1997009428A2 (pt)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6641814B1 (en) 1997-04-02 2003-11-04 Statens Serum Institut Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
JP2001500383A (ja) * 1996-10-11 2001-01-16 コリックサ コーポレーション 結核診断用の化合物および方法
US6627198B2 (en) 1997-03-13 2003-09-30 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis antigens and their uses
US6544522B1 (en) * 1998-12-30 2003-04-08 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
US6350456B1 (en) 1997-03-13 2002-02-26 Corixa Corporation Compositions and methods for the prevention and treatment of M. tuberculosis infection
JP4172598B2 (ja) * 1997-04-02 2008-10-29 スタテンス セールム インスティトゥート 結核菌由来の核酸フラグメント及びポリペプチドフラグメント
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
US6555653B2 (en) 1997-05-20 2003-04-29 Corixa Corporation Compounds for diagnosis of tuberculosis and methods for their use
US6613881B1 (en) * 1997-05-20 2003-09-02 Corixa Corporation Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
US6436409B1 (en) * 1997-07-16 2002-08-20 Institut Pasteur Polynucleotide functionally coding for the LHP protein from Mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same
EP1484405A1 (en) * 1997-11-10 2004-12-08 Statens Serum Institut Nucleic acid fragments and polypeptide fragments derived from M. Tuberculosis
WO1999024577A1 (en) * 1997-11-10 1999-05-20 Statens Serum Institut NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)
WO1999051748A2 (en) * 1998-04-07 1999-10-14 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
GB9808720D0 (en) * 1998-04-23 1998-06-24 Smithkline Beecham Biolog Novel compounds
US7632646B1 (en) * 1998-11-04 2009-12-15 Isis Innovation Limited Tuberculosis diagnostic test
AU2594500A (en) * 1998-12-24 2000-07-31 Corixa Corporation Methods for using mycobacterium tuberculosis molecules as immunological adjuvants
US6465633B1 (en) 1998-12-24 2002-10-15 Corixa Corporation Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
ES2326257T3 (es) 1999-05-04 2009-10-06 The University Of Medicine And Dentistry Of New Jersey Proteinas expresadas por mycobacterium tuberculosis y no por bcg y su utilizacion como reactivos diagnosticos y vacunas.
US7009042B1 (en) * 1999-10-07 2006-03-07 Corixa Corporation Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
AU2001241738A1 (en) 2000-02-25 2001-09-03 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
ATE442866T1 (de) 2000-06-20 2009-10-15 Corixa Corp Fusionsproteine aus mycobakterium tuberculosis
US7026465B2 (en) 2002-02-15 2006-04-11 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis
ITRM20040091A1 (it) 2004-02-19 2004-05-19 Istituto Naz Per Le Malattie Test immunologico rapido per la diagnosi ed il monitoraggio dell'infezione tubercolare.
FI119445B (fi) * 2004-10-29 2008-11-14 Waertsilae Finland Oy Polttomoottorin polttoaineen syöttöjärjestelmän paineen värähtelyn vaimennin
KR101255870B1 (ko) 2004-11-16 2013-04-17 아에라스 글로벌 티비 백신 파운데이션 재조합 바이러스 벡터를 포함하는 다가 백신
PL2457926T3 (pl) 2005-04-29 2015-03-31 Glaxosmithkline Biologicals Sa Nowy sposób profilaktyki lub leczenia zakażenia m. tuberculosis
FR2952058B1 (fr) * 2009-10-29 2013-10-04 Centre Nat Rech Scient Procede de ligation native de polypeptides
SG182573A1 (en) 2010-01-27 2012-08-30 Glaxosmithkline Biolog Sa Modified tuberculosis antigens
WO2012080370A1 (en) 2010-12-14 2012-06-21 Glaxosmithkline Biologicals S.A. Mycobacterium antigenic composition
FR2971509B1 (fr) * 2011-02-16 2013-02-22 Centre Nat Rech Scient Procede de preparation de peptides par assemblage de multiples fragments peptidiques
CN103290030A (zh) * 2012-02-23 2013-09-11 上海交通大学 一种结核分枝杆菌标志物HtdY的重组蛋白及其制备方法和临床应用
HUE044612T2 (hu) * 2012-05-04 2019-11-28 Pfizer Prosztata-asszociált antigének és vakcina-alapú immunterápiás rendek
CN111233992B (zh) * 2014-04-04 2024-07-19 韦斯塔隆公司 人工活化的肽
GB201513176D0 (en) 2015-07-27 2015-09-09 Glaxosmithkline Biolog Sa Novel methods for inducing an immune response
FR3048286B1 (fr) * 2016-02-26 2021-01-22 Omunis Peptides immunogenes et leur utilisation
CN107304231B (zh) * 2016-04-18 2021-01-01 华中农业大学 一种结核分枝杆菌融合蛋白及应用
GB201614485D0 (en) * 2016-08-25 2016-10-12 Univ Oxford Innovation Ltd Immunogenic composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244539A1 (en) * 1973-07-13 1975-04-18 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
FR2265402A1 (en) * 1974-03-29 1975-10-24 Mitsui Pharmaceuticals Tuberculin active proteins and peptides prepn - from tubercle bacillus
US4876089A (en) * 1984-09-06 1989-10-24 Chiron Corporation Feline leukemia virus protein vaccines
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
FR2677365B1 (fr) * 1991-06-07 1995-08-04 Pasteur Institut Proteines de mycobacterium et applications.
US5330754A (en) * 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
DK79893D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut New vaccine
DK79793D0 (da) * 1993-07-02 1993-07-02 Statens Seruminstitut Diagnostic test

Also Published As

Publication number Publication date
WO1997009428A2 (en) 1997-03-13
EP1203817A2 (en) 2002-05-08
JP2009159982A (ja) 2009-07-23
EP1203817B1 (en) 2006-04-12
PT1398379E (pt) 2007-01-31
DK1203817T3 (da) 2006-08-14
PL325373A1 (en) 1998-07-20
AU727602B2 (en) 2000-12-14
CN1200147A (zh) 1998-11-25
CZ300953B6 (cs) 2009-09-23
JP2001517069A (ja) 2001-10-02
NO20070621L (no) 1998-04-27
CA2230885A1 (en) 1997-03-13
NO20070618L (no) 1998-04-27
IL123506A0 (en) 1998-10-30
ES2324529T3 (es) 2009-08-10
CY2612B2 (en) 2010-12-22
ES2262595T3 (es) 2006-12-01
DK1398379T3 (da) 2007-01-08
AU7158696A (en) 1997-03-27
CA2653566C (en) 2013-06-25
EP0851927A2 (en) 1998-07-08
CA2684425A1 (en) 1997-03-13
EP0851927B1 (en) 2003-10-22
CA2230885C (en) 2010-02-02
NO336288B1 (no) 2015-07-13
TR200901109T1 (tr) 2012-02-21
WO1997009428A3 (en) 1997-07-17
ATE337399T1 (de) 2006-09-15
BR9612997B1 (pt) 2012-01-10
CZ62898A3 (cs) 1999-10-13
DE69636487D1 (de) 2006-10-05
HUP9900902A3 (en) 2001-03-28
TR200806259T2 (tr) 2008-10-21
EP1347055A2 (en) 2003-09-24
EP1347055A3 (en) 2003-11-26
DE69636046T2 (de) 2006-11-23
DK1347055T3 (da) 2009-06-29
NO980883L (no) 1998-04-27
NO20070619L (no) 1998-04-27
DK0851927T3 (da) 2004-01-26
HUP9900902A2 (hu) 1999-07-28
DE69636046D1 (de) 2006-05-24
EP1347055B1 (en) 2009-03-18
EP1203817A3 (en) 2003-01-29
ATE513915T1 (de) 2011-07-15
JP4324596B2 (ja) 2009-09-02
HU225979B1 (en) 2008-02-28
EP1712628A3 (en) 2007-05-23
MX9801638A (es) 1998-05-31
JP4324618B2 (ja) 2009-09-02
JP2006149406A (ja) 2006-06-15
HU227778B1 (en) 2012-02-28
JP4382160B2 (ja) 2009-12-09
TR200403064T2 (tr) 2005-08-22
HK1059282A1 (en) 2004-06-25
EP1712628A2 (en) 2006-10-18
DE69630457D1 (de) 2003-11-27
DE69630457T2 (de) 2004-11-25
PL186774B1 (pl) 2004-02-27
ATE323165T1 (de) 2006-04-15
CZ297406B6 (cs) 2006-12-13
DE69637879D1 (de) 2009-04-30
EP1398379A2 (en) 2004-03-17
JP2006187292A (ja) 2006-07-20
IL123506A (en) 2004-12-15
KR100433750B1 (ko) 2004-09-01
KR19990044347A (ko) 1999-06-25
EP1712628B1 (en) 2011-06-22
CN1117149C (zh) 2003-08-06
EP1398379A3 (en) 2004-07-14
ATE426025T1 (de) 2009-04-15
EP1203817B9 (en) 2006-08-16
TR199800411T1 (xx) 1998-05-21
NZ319377A (en) 2000-01-28
JP2007228972A (ja) 2007-09-13
NO324372B1 (no) 2007-10-01
ATE252640T1 (de) 2003-11-15
TR200806258T2 (tr) 2008-10-21
BR9610262B1 (pt) 2013-11-26
CA2653566A1 (en) 1997-03-13
BR9610262A (pt) 1999-07-06
SI0851927T1 (en) 2004-02-29
CZ300688B6 (cs) 2009-07-15
DE69636487T2 (de) 2007-05-03
CY2570B1 (en) 2008-07-02
JP4324597B2 (ja) 2009-09-02
EP1398379B1 (en) 2006-08-23
PT1203817E (pt) 2006-08-31
PT851927E (pt) 2004-03-31
NO980883D0 (no) 1998-02-27
ES2210392T3 (es) 2004-07-01
ES2271449T3 (es) 2007-04-16

Similar Documents

Publication Publication Date Title
CY2570B1 (en) Compounds for immunotherapy and diagnosis of tuberculosis
WO1998016646A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO1998053075A3 (en) Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
WO1999042076A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO2002024739A3 (en) Spas-1 cancer antigen
AR010517A1 (es) Compuestos y metodos para la inmunoterapia y diagnostico de tuberculosis
CY1108864T1 (el) Ενωσεις για ανοσοθεραπεια και διαγνωση φυματιωσης και μεθοδοι χρησεις τους